NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE American · Medical Devices · USD

InfuSystem Holdings, Inc. (INFU) Stock Analysis

InfuSystem Holdings, Inc. (INFU) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

INFU

$12.24

+$0.06 (+0.49%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare INFU with… →

INFU Key Statistics

As of Sep 4, 2026
Trading
Open
$12.10
Previous Close
$12.18
Day's Range
12.10–12.35
52-Week Range
7.29–12.97
Volume
83.20K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.50
Valuation
Market Cap
$243.79M
P/E Ratio
30.60
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
27.82
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.73
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.70
EPS (ttm)Profit attributable to each share over the last twelve months.
0.40
Financials (FY)
Revenue (FY)
$143.44M+6.36%
Net Income (FY)
$6.63M+182.60%
Profit marginThe share of revenue left as profit after all costs and taxes.
5.96%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
19.92M
1-Year Return
+15.15%
Dividend and dates
Earnings Date
November 3, 2026
Avg Volume
189.22K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

INFU Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+36.45%
2025+6.15%
2024−19.83%
2023+21.43%
2022−49.03%
2021−9.32%
2020+120.16%
2019+147.97%
2018+49.57%
2017−9.80%
2016 (partial year)−11.76%

As of September 4, 2026.

INFU Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$143.44M$6.63M4.6%
2024$134.86M$2.35M1.7%
2023$125.79M$872.00K0.7%
2022$109.91M$18.00K0.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$143.44M$80.30M$11.92M$6.63M4.6%
2024$134.86M$70.40M$6.89M$2.35M1.7%
2023$125.79M$63.11M$4.09M$872.00K0.7%
2022$109.91M$60.56M$1.65M$18.00K0.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

INFU Valuation vs Medical Devices Median

Median of 151 stocks
MetricINFUMedical Devices medianvs median
P/E30.6026.8014% above
P/S ratio1.702.9843% below
Profit margin5.96%−1.69%7.7 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

InfuSystem Holdings, Inc. (INFU) is capitalised at $243.79M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 461.

Over the past 52 weeks the price has ranged from $7.29 to $12.97. INFU last closed at $12.24 on September 4, 2026. That is +$0.06 (+0.49%) against the previous close. The latest close sits 67.9% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $143.44M. That is +6.36% against the prior fiscal year, when revenue was $134.86M. Net income for the same year was $6.63M. That is +182.60% against the prior fiscal year. The reported profit margin is 5.96%. That is 7.7 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 0.4.

Across the 4 fiscal years on file, revenue moves from $109.91M in 2022 to $143.44M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

INFU trades at a trailing price-to-earnings ratio of 30.6. That is 14.18% above the Medical Devices median of 26.8. The forward P/E on file is 27.82. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.73. Measured against sales, the shares trade at 1.7 times revenue. On price-to-sales that is 42.85% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Beta against the wider market is reported at 1.5. Annualized volatility over the trailing 10 years is 55.36%. Over the trailing twelve months the price has returned +15.15%. Across 10 years the annualized return works out at +15.85%.

Growth & Income

The record shows no dividend for INFU.

So far in 2026 the price is +36.45%. The strongest complete calendar year on file is 2019 at +147.97%; the weakest is 2022 at −49.03%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

InfuSystem Holdings, Inc. (INFU) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
InfuSystem Holdings, Inc. INFU $243.79M 30.6
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. InfuSystem Holdings, Inc. trades at a P/E of 30.6.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Visit website →